Alaunos Therapeutics, Inc. (TCRT) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by and welcome to the Alano's Therapeutics fourth quarter and full year 2021 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions will follow at that time. If you require operator assistance during the program, please press star zero. I will now turn the call over to your host, Alex Lobo, Stern Investor Relations. You may begin. Good morning and welcome to Alano's Therapeutics fourth quarter and full year 2021 financial results conference call and audio webcast. With me today are Kevin Boyle Sr., ALANA's Therapeutics Chief Executive Officer, Drew Dennegar, Vice President of Research and Development, and Mike Wong, our Vice President of Finance. Earlier this morning, ALANA's issued a press release announcing financial results for the three months and full year ended December 31st, 2021. We encourage everyone to read today's press release as well as the ALANA's annual report on Form 10-K for the year ended December 31st, 2021. which was filed this morning with the SEC. The company's press release and annual report will also be available on the Elanos website at elanos.com. In addition, this conference call is being webcast through the investor relations section of the company's website and will be archived there for future reference. Please note that certain information discussed on today's call is covered under the safe harbor provision of the private securities litigation reform act of 1995. Participants are cautioned that this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, March 30, 2022. Actual results could differ materially from those stated or i...